Goldenwell Biotech (GWLL) Net Income (2019 - 2025)
Goldenwell Biotech (GWLL) has disclosed Net Income for 7 consecutive years, with -$7985.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Net Income rose 68.27% year-over-year to -$7985.0, compared with a TTM value of $22483.0 through Sep 2025, up 117.42%, and an annual FY2024 reading of -$131498.0, down 12.05% over the prior year.
- Net Income was -$7985.0 for Q3 2025 at Goldenwell Biotech, down from -$5220.0 in the prior quarter.
- Across five years, Net Income topped out at $70065.0 in Q4 2024 and bottomed at -$920334.0 in Q4 2022.
- Average Net Income over 5 years is -$68738.2, with a median of -$27084.0 recorded in 2023.
- The sharpest move saw Net Income crashed 16234.25% in 2021, then soared 436.87% in 2024.
- Year by year, Net Income stood at -$29554.0 in 2021, then tumbled by 3014.08% to -$920334.0 in 2022, then surged by 97.74% to -$20799.0 in 2023, then skyrocketed by 436.87% to $70065.0 in 2024, then crashed by 111.4% to -$7985.0 in 2025.
- Business Quant data shows Net Income for GWLL at -$7985.0 in Q3 2025, -$5220.0 in Q2 2025, and -$34377.0 in Q1 2025.